MediXall (MDXL) Revenue (2021 - 2024)
MediXall's Revenue history spans 4 years, with the latest figure at $38858.0 for Q3 2024.
- For Q3 2024, Revenue fell 40.71% year-over-year to $38858.0; the TTM value through Sep 2024 reached $304336.0, up 29.41%, while the annual FY2023 figure was $309422.0, 422.07% up from the prior year.
- Revenue reached $38858.0 in Q3 2024 per MDXL's latest filing, down from $52839.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $166642.0 in Q2 2021 to a low of $3271.0 in Q1 2021.
- Average Revenue over 4 years is $50616.2, with a median of $38858.0 recorded in 2024.
- Peak YoY movement for Revenue: tumbled 93.79% in 2022, then skyrocketed 884.77% in 2023.
- A 4-year view of Revenue shows it stood at $7028.0 in 2021, then skyrocketed by 188.03% to $20243.0 in 2022, then skyrocketed by 366.81% to $94497.0 in 2023, then tumbled by 58.88% to $38858.0 in 2024.
- Per Business Quant, the three most recent readings for MDXL's Revenue are $38858.0 (Q3 2024), $52839.0 (Q2 2024), and $118142.0 (Q1 2024).